Humacyte stock surges over 50% on FDA approval
-- Shares of Humacyte Inc. soared +56% in pre-open trading Friday following the announcement that the U.S. Food and Drug Administration (FDA) has granted full...
-- Shares of Humacyte Inc. soared +56% in pre-open trading Friday following the announcement that the U.S. Food and Drug Administration (FDA) has granted full...
-- Oil supplies through Russia's Druzhba pipeline, which links Russian oil fields to European refineries, have been halted since December 19, according to sources...
-- On Friday, Russia's central bank announced that it will keep its primary interest rates steady at 21%. This move was unexpected, as the market had widely predicted...
-- Ionis Pharmaceuticals (NASDAQ:IONS) shares climbed 6% in pre-open trading Friday after announcing the U.S. Food and Drug Administration (FDA) approval of...
-- Bitcoin's value plummeted approximately 9% on Friday, as the cryptocurrency market experienced a sharp sell-off, possibly reflecting a broader investor retreat...
-- Former Nissan (OTC:NSANY) Motor Co. chairman, Carlos Ghosn, has commented on the potential deal between Nissan and Honda Motor Co (NYSE:HMC)., labeling it a...
-- Occidental Petroleum (NYSE:OXY) shares climbed 2.3% in pre-open trading Friday after Warren Buffett's Berkshire Hathaway (NYSE:BRKa) has significantly increased...
-- Shares of Novo Nordisk (NYSE:NVO) A/S, the Danish pharmaceutical company, experienced a significant drop following the release of less than anticipated results...
-- Jared Kushner's investment firm, Affinity Partners, has secured an additional $1.5 billion in funding from the Qatar Investment Authority and Abu Dhabi-based asset...
-- European stock markets fell Friday, as investors fretted about the potential of a trade war with the US, while digesting more important economic data. At 06:50 ET...